Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: Prospective cohort study from a hospital in Argentina
Background: In December 2020, Sputnik V was incorporated to the National COVID-19 Immunization Plan in Argentina. Studies had shown 98% of antibody response rate. To date, data on immunogenicity and antibody persistence in Argentina are scarce.The objective was to assess humoral immune response afte...
Main Authors: | A. Gentile, V.E. Castellano, A. Pacchiotti, N. Weinberger, S. Diana Menéndez, M. del Pino, G. Carciofi, P. Lamy, A.S. Mistchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259013622200047X |
Similar Items
-
Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
by: Gennady T. Sukhikh, et al.
Published: (2022-10-01) -
Sobre la vacuna rusa Sputnik V y su eficacia
by: Carlos Jiménez
Published: (2021-04-01) -
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
by: Andrey S. Shkoda, et al.
Published: (2022-06-01) -
Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level
by: Mikhail A. Godkov, et al.
Published: (2022-12-01) -
Effect of the Previous History of the SARS-CoV-2 Infections on Antibody Levels among Sputnik V Vaccinated Healthcare Workers
by: Atieh Yaghoubi, et al.
Published: (2023-03-01)